Clinical Trial Of New Multiple Sclerosis Treatment
Links shared publicly online about this topic.
- 1,054total visits
Clinical Trial Of New Multiple Sclerosis Treatment
View full resource at medicalnewstoday.com
Tags: Neurology, Multiple Sclerosis, Clinical Trial, Neurosurgery
Most Recently Shared on July 2, 2010 at 1:02 pm By:
Clinical Trial Of New Multiple Sclerosis Treatment: Buffalo medical researchers led by a team from the University ... http://mnt.to/f/3FD5
Also Shared By:
Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS
eurekalert.org — “People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21-28, 2012.” View full resource at eurekalert.org
Most Recently Shared on April 20, 2012 at 7:17 am By:
Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS: ( American Acade... http://t.co/DJO0pAcf
JAK-STAT inhibitors reverse MS-like disease in mice
news-medical.net — “A new class of drugs completing clinical trials soon for rheumatoid arthritis should be examined as a treatment for multiple sclerosis, according to the authors of a University of Alabama at Birmingham study published today in the Proceedings of the National Academy of Sciences.” View full resource at news-medical.net
Most Recently Shared on March 13, 2012 at 6:05 am By:
JAK-STAT inhibitors reverse MS-like disease in mice: A new class of drugs completing clinical trials soon for rh... http://t.co/VNwZIqB3
UAB - Arthritis drugs hold promise for multiple sclerosis
uab.edu — “A new class of drugs completing clinical trials soon for rheumatoid arthritis should be examined as a treatment for multiple sclerosis, according to t...” View full resource at uab.edu
Most Recently Shared on March 12, 2012 at 7:39 pm By:
Arthritis drugs hold promise for multiple sclerosis http://t.co/TfM15Qci
From the Front Lines: MS Research to Follow in 2012 - Yahoo! News
news.yahoo.com — “From Yahoo! News: National MS Society Live Webcast December 13 Will Offer MS News You Can Use From Internationally Renowned ResearchersNew York, NY (PRWEB) December 08, 2011 This year saw exciting research progress in efforts to stop multiple sclerosis, restore function that’s been lost and end the disease entirely. At least three emerging therapies are advancing through the pipeline toward FDA review while at least four clinical trials focusing on progressive MS continue to move forward. ...” View full resource at news.yahoo.com
Most Recently Shared on December 8, 2011 at 6:32 pm By:
Urology & Nephrology OW Health
From the Front Lines: MS Research to Follow in 2012: National MS Society Live Webcast December 13 Will Offer MS ... http://t.co/djKi2Zz0
Medical News: MS Markers Match Disability Progression - in Clinical Context, Multiple Sclerosis from MedPage Today
medpagetoday.com — “Two surrogate markers commonly used in multiple sclerosis clinical trials are near-perfect measures of the effect of treatment with interferon, researchers reported.” View full resource at medpagetoday.com
Most Recently Shared on November 3, 2011 at 8:38 pm By:
Patricia Grace Eldercare Expert
MS Markers Match Disability Progression (CME/CE): (MedPage Today) -- Two surrogate markers commonly used in mult... http://t.co/yjYBCgid
Biogen Idec Reveals Clinical Data for (Really) Small Oral MS Drug BG-12 | The Haystack
cenblog.org — “Biogen Idec made a splash last week when its oral medication for multiple sclerosis (MS), BG-12, was found to reduce relapses in 44-53% of nearly 3,800 patients in two separate Phase 3 clinical trials (CONFIRM and DEFINE, respectively). Continued hopes for an orally available, non-injectable MS treatment have created a race between Biogen Idec and several [...]” View full resource at cenblog.org
Most Recently Shared on November 2, 2011 at 12:15 pm By:
Carmen Drahl Doctor, Science Enthusiast, and PhD
Biogen's MS drug candidate BG-12 bucks the trend for REALLY small molecules in drug development, says @SeeArrOh http://t.co/Q4RkDJPB $BIIB
New Drug Shows Promise Against Multiple Sclerosis
medicalnewstoday.com — “An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affe” View full resource at medicalnewstoday.com
Most Recently Shared on November 2, 2011 at 10:06 am By:
New Drug Shows Promise Against Multiple Sclerosis: An experimental drug called Ocrelizumab has shown promise in ... http://t.co/fLu7f3Em
New Multiple Sclerosis Therapy Promising in Early Trial - Drugs.com MedNews
drugs.com — “Multiple sclerosis patients may eventually benefit from a novel treatment that takes aim at the abnormal behavior of a specific type of immune cell, preliminary” View full resource at drugs.com
Most Recently Shared on November 1, 2011 at 5:24 pm By:
New Multiple Sclerosis Therapy Promising in Early Trial - http://t.co/ivm3Zqtk
New Multiple Sclerosis Therapy Promising in Early Trial - iVillage
ivillage.com — “TUESDAY, Nov. 1 (HealthDay News) -- Multiple sclerosis patients may eventually benefit from a novel treatment that takes aim at the abnormal behavior of a specific type of immune cell, preliminary research suggests. The errant behavior of the” View full resource at ivillage.com
Most Recently Shared on November 1, 2011 at 3:49 pm By:
New Multiple Sclerosis Therapy Promising in Early Trial http://t.co/P1iK4691
New Method Isolates Best Brain Stem Cells To Treat MS
medicalnewstoday.com — “The prospect of doing human clinical trials with stem cells to treat diseases like multiple sclerosis may be growing closer, say scientists at the University at Buffalo and the University at Roche” View full resource at medicalnewstoday.com
Most Recently Shared on October 14, 2011 at 8:05 am By:
MNT Stem Cell News Health News
New Method Isolates Best Brain Stem Cells To Treat MS http://t.co/pa5RcHan #stemcell
Relapses Reduced In Multiple Sclerosis Patients By New Oral Drug
medicalnewstoday.com — “A new oral drug has been shown in a large international clinical trial to significantly reduce the relapse rate of people with multiple sclerosis and to slow the progression of the disease.” View full resource at medicalnewstoday.com
Most Recently Shared on October 9, 2011 at 7:05 am By:
Relapses Reduced In Multiple Sclerosis Patients By New Oral Drug: A new oral drug has been shown in a large inte... http://t.co/kQwyG9eX
New Study Is The First North American Clinical Trial To Test Adult Mesenchymal Stem Cell Transplantation As A New Therapy For MS
medicalnewstoday.com — “A team of researchers at three landmark Cleveland institutions have come together to launch a new clinical trial of an experimental treatment for multiple sclerosis (MS). Researchers at the Clevel” View full resource at medicalnewstoday.com
Most Recently Shared on August 26, 2011 at 8:05 am By:
MNT Clinical Trials Health News
New Study Is The First North American Clinical Trial To Test Adult Mesenchymal Stem Cell Transplantation As A New Ther... http://mnt.to/3Zck
SCCA Clinical Trials | Multiple Myeloma | NCT01208662
seattlecca.org — “A Randomized Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients up to 65 Years of Age (IFM/DFCI 2009) Seattle Cancer Care Alliance is a nationally recognized treatment center that provides advanced therapies and clinical trials for cancers and other blood disorders. SCCA unites the doctors and technology from Fred ” View full resource at seattlecca.org
Most Recently Shared on August 25, 2011 at 7:27 pm By:
ReedMedicalEducation Medical Education
RT @seattlecca: New! Multiple myeloma trial compares combo of lenalidomide, bortezomib and dexamethasone (RVD) to BMT. http://ow.ly/69xMR
First North American clinical trial to test adult MSC transplantation as a new MS therapy
news-medical.net — “A team of researchers at three landmark Cleveland institutions have come together to launch a new clinical trial of an experimental treatment for multiple sclerosis.” View full resource at news-medical.net
Most Recently Shared on August 24, 2011 at 5:37 am By:
Genetics News: First North American clinical trial to test adult MSC transplantation as a new MS therapy: A team... http://t.co/gsT3d45
Actelion's selective S1P1 receptor agonist ponesimod successful in mid-stage trial for multiple sclerosis - Ponesimod to proceed to Phase III final stage of clinical development - Drugs.com MedNews
drugs.com — “ALLSCHWIL BASEL, SWITZERLAND - 02 August 2011 - Actelion (SIX ATLN) announced today that the primary endpoint - reduction in the number of new active inflammato” View full resource at drugs.com
Most Recently Shared on August 3, 2011 at 12:02 pm By:
Drugs and Devices OW OW Health
Actelion's selective S1P1 receptor agonist ponesimod successful in mid-stage trial for multiple sclerosis ... http://bit.ly/oQOawi #drug
Advertisement
MNT Multiple Scl
@mnt_multiplescl
New Study Is The First North American Clinical Trial To Test Adult Mesenchymal Stem Cell Transplantation As A New Ther... http://mnt.to/3Zck
1 year ago...